المؤلفون: Fabian KP; Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA., Kowalczyk JT; Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA., Reynolds ST; Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA., Hodge JW; Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

المصدر: Cells [Cells] 2022 Nov 29; Vol. 11 (23). Date of Electronic Publication: 2022 Nov 29.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101600052 Publication Model: Electronic Cited Medium: Internet ISSN: 2073-4409 (Electronic) Linking ISSN: 20734409 NLM ISO Abbreviation: Cells Subsets: MEDLINE

مواضيع طبية MeSH: Immunogenic Cell Death* , Neoplasms*/drug therapy, Humans ; Immunotherapy/methods ; Immunity

المؤلفون: Galluzzi L; Department of Radiation Oncology, Weill Cornell Medical College, New York City, New York, USA deadoc80@gmail.com.; Sandra and Edward Meyer Cancer Center, New York City, New York, USA.; Caryl and Israel Englander Institute for Precision Medicine, New York City, New York, USA.; Department of Dermatology, Yale School of Medicine, New Haven, Connecticut, USA.; Université de Paris, Paris, France., Vitale I; IIGM - Italian Institute for Genomic Medicine, c/o IRCSS, Candiolo, Torino, Italy.; Candiolo Cancer Institute, FPO - IRCCS, Candiolo, Italy., Warren S; NanoString Technologies, Seattle, Washington, USA., Adjemian S; VIB Center for Inflammation Research (IRC), Ghent, Belgium.; Department of Biomedical Molecular Biology (DBMB), Ghent University, Ghent, Belgium., Agostinis P; Cell Death Research & Therapy (CDRT) Laboratory, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium.; VIB-KU Leuven Center for Cancer Biology, KU Leuevn, Leuven, Belgium., Martinez AB; Department of Radiation Oncology, Weill Cornell Medical College, New York City, New York, USA., Chan TA; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York City, New York, USA.; Immunogenomics and Precision Oncology Platform, Memorial Sloan Kettering Cancer Center, New York City, New York, USA., Coukos G; Ludwig Institute for Cancer Research and Department of Oncology, University of Lausanne, Lausanne, Switzerland., Demaria S; Department of Radiation Oncology, Weill Cornell Medical College, New York City, New York, USA.; Sandra and Edward Meyer Cancer Center, New York City, New York, USA.; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York City, New York, USA., Deutsch E; Department of Radiation Oncology, Gustave Roussy Cancer Campus, Villejuif, France.; INSERM 'Molecular Radiotherapy and therapeutic innovation', U1030 Molecular Radiotherapy, Gustave Roussy Cancer Campus, Villejuif, France.; SIRIC SOCRATES, DHU Torino, Faculté de Medecine, Université Paris-Saclay, Kremlin-Bicêtre, France., Draganov D; Calidi Biotherapeutics, San Diego, California, USA., Edelson RL; Department of Dermatology, Yale School of Medicine, New Haven, Connecticut, USA.; Comprehensive Cancer Center, Yale University School of Medicine, New Haven, Connecticut, USA., Formenti SC; Department of Radiation Oncology, Weill Cornell Medical College, New York City, New York, USA.; Sandra and Edward Meyer Cancer Center, New York City, New York, USA., Fucikova J; Department of Immunology, Charles University, 2nd Faculty of Medicine and University Hospital Motol, Prague, Czech Republic.; Sotio, Prague, Czech Republic., Gabriele L; Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy., Gaipl US; Universitätsklinikum Erlangen, Erlangen, Germany., Gameiro SR; Laboratory of Tumor Immunology and Biology, National Cancer Institute/Center for Cancer Research, National Institutes of Health, Bethesda, Maryland, USA., Garg AD; Cell Death Research & Therapy (CDRT) Laboratory, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium., Golden E; Department of Radiation Oncology, Weill Cornell Medical College, New York City, New York, USA.; Sandra and Edward Meyer Cancer Center, New York City, New York, USA., Han J; iRepertoire, Inc, Huntsville, Alabama, USA., Harrington KJ; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK.; The Royal Marsden Hospital/Institute of Cancer Research National Institute for Health Biomedical Research Centre, London, UK., Hemminki A; Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland.; Comprehensive Cancer Center, Helsinki University Hospital, Helsinki, Finland., Hodge JW; Laboratory of Tumor Immunology and Biology, National Cancer Institute/Center for Cancer Research, National Institutes of Health, Bethesda, Maryland, USA., Hossain DMS; Merck & Co. Inc, Kenilworth, New Jersey, USA., Illidge T; University of Manchester, NIHR Manchester Biomedical Research Centre, Christie Hospital, Manchester, UK., Karin M; Department of Pharmacology and Pathology, University of California at San Diego (UCSD) School of Medicine, La Jolla, California, USA., Kaufman HL; Division of Surgical Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA.; Replimune, Inc, Woburn, Massachusetts, USA., Kepp O; Metabolomics and Cell Biology Platforms, Gustave Roussy Comprehensive Cancer Institute, Villejuif, France.; Equipe 11 labellisée Ligue contre le Cancer, Centre de Recherche des Cordeliers, Paris, France., Kroemer G; Université de Paris, Paris, France.; Metabolomics and Cell Biology Platforms, Gustave Roussy Comprehensive Cancer Institute, Villejuif, France.; Equipe 11 labellisée Ligue contre le Cancer, Centre de Recherche des Cordeliers, Paris, France.; Gustave Roussy Comprehensive Cancer Institute, Villejuif, France.; INSERM, U1138, Paris, France.; Sorbonne Université, Paris, France.; Pôle de Biologie, Hôpital Européen Georges Pompidou, AP-HP, Paris, France.; Karolinska Institute, Department of Women's and Children's Health, Karolinska University Hospital, Stockholm, Sweden.; Suzhou Institute for Systems Medicine, Chinese Academy of Medical Sciences, Suzhou, China., Lasarte JJ; Program of Immunology and Immunotherapy, Centro de Investigación Médica Aplicada (CIMA), University of Navarra, Pamplona, Spain., Loi S; Division of Research and Clinical Medicine, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Department of Oncology, University of Melbourne, Parkville, Victoria, Australia., Lotze MT; Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.; Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.; Department of Bioengineering, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA., Manic G; IIGM - Italian Institute for Genomic Medicine, c/o IRCSS, Candiolo, Torino, Italy.; Candiolo Cancer Institute, FPO - IRCCS, Candiolo, Italy., Merghoub T; Ludwig Collaborative and Swim Across America Laboratory, MSKCC, New York City, New York, USA.; Weill Cornell Medical College, New York City, New York, USA.; Parker Institute for Cancer Immunotherapy, MSKCC, New York City, New York, USA., Melcher AA; The Institute of Cancer Research, London, UK., Mossman KL; McMaster University, Hamilton, Ontario, Canada., Prosper F; Hematology and Cell Therapy, Clinica Universidad de Navarra, Pamplona, Spain., Rekdal Ø; Lytix Biopharma, Oslo, Norway.; Department of Medical Biology, University of Tromsø, Tromsø, Norway., Rescigno M; Humanitas Clinical and Research Center - IRCCS, Rozzano, Italy.; Humanitas University, Department of Biomedical Sciences, Pieve Emanuele, Milan, Italy., Riganti C; Department of Oncology, University of Torino, Torino, Italy.; Interdepartmental Research Center of Molecular Biotechnology, University of Torino, Torino, Italy., Sistigu A; UOSD Immunology and Immunotherapy Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.; Istituto di Patologia Generale, Università Cattolica del Sacro Cuore, Rome, Italy., Smyth MJ; Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Spisek R; Department of Immunology, Charles University, 2nd Faculty of Medicine and University Hospital Motol, Prague, Czech Republic.; Sotio, Prague, Czech Republic., Stagg J; Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Montréal, Quebec City, Canada.; Institut du Cancer de Montréal, Montréal, Quebec City, Canada.; Faculté de Pharmacie de l'Université de Montréal, Montréal, Quebec City, Canada., Strauss BE; Centro de Investigação Translacional em Oncologia/LIM24, Instituto do Câncer do Estado de São Paulo, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brasil., Tang D; Department of Surgery, UT Southwestern Medical Center, Dallas, Texas, USA., Tatsuno K; Department of Dermatology, Yale School of Medicine, New Haven, Connecticut, USA., van Gool SW; Immun-Onkologisches Zentrum Köln, Cologne, Germany., Vandenabeele P; VIB Center for Inflammation Research (IRC), Ghent, Belgium.; Department of Biomedical Molecular Biology (DBMB), Ghent University, Ghent, Belgium.; Methusalem program, Ghent University, Ghent, Belgium., Yamazaki T; Department of Radiation Oncology, Weill Cornell Medical College, New York City, New York, USA., Zamarin D; Department of Medicine, Weill Cornell Medical College, New York City, New York, USA.; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York City, New York, USA., Zitvogel L; Gustave Roussy Comprehensive Cancer Institute, Villejuif, France.; Equipe labellisée par la Ligue contre le cancer, Gustave Roussy, Villejuif, France.; Faculty of Medicine, University of Paris Sud/Paris Saclay, Le Kremlin-Bicêtre, France.; INSERM U1015, Villejuif, France.; Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 1428, Villejuif, France., Cesano A; ESSA Pharmaceuticals, South San Francisco, California, USA., Marincola FM; Refuge Biotechnologies, Menlo Park, California, USA.

المصدر: Journal for immunotherapy of cancer [J Immunother Cancer] 2020 Mar; Vol. 8 (1).

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Review

بيانات الدورية: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Immunogenic Cell Death/*genetics , Molecular Biology/*methods, Consensus ; Guidelines as Topic ; Humans

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Kepp, O., Senovilla, L., Vitale, I., Vacchelli, E., Adjemian, S., Agostinis, P., Apetoh, L., Aranda, F., Barnaba, V., Bloy, N., Bracci, L., Breckpot, K., Brough, D., Buqué, A., Castro, Mg, Cirone, M., Colombo, Mi, Cremer, I., Demaria, S., Dini, L., Eliopoulos, A., Faggioni, A., Formenti, Sc, Fu??íková, J., Gabriele, L., Gaipl, Us, Galon, J., Garg, A., Ghiringhelli, F., Giese, Na, Guo, Zs, Hemminki, A., Herrmann, M., Hodge, Jw, Holdenrieder, S., Honeychurch, J., Hm, Hu, Huang, X., Illidge, Tm, Kono, K., Korbelik, M., Krysko, Dv, Loi, S., Lowenstein, Pr, Lugli, E., Ma, Y., Madeo, F., Manfredi, Aa, Martins, I., Matzinger, P., Mavilio, D., Menger, L., Merendino, N., Michaud, M., Mignot, G., Mossman, Kl, Multhoff, G., Oehler, R., Palombo, F., Panaretakis, T., Pol, J., Proietti, E., Ricci, Je, Riganti, Chiara, Rovere Querini, P., Rubartelli, A., Sistigu, A., Smyth, Mj, Sonnemann, J., Spisek, R., Stagg, J., Sukkurwala, Aq, Tartour, E., Thorburn, A., Thorne, Sh, Vandenabeele, P., Velotti, F., Workenhe, Sr, Yang, H., Zong, Wx, Zitvogel, L., Kroemer, G., Galluzzi, L.

المساهمون: Medicine and Pharmacy academic/administration, Basic (bio-) Medical Sciences, Laboratory of Molecullar and Cellular Therapy, Chemistry, Kepp, Oliver, Senovilla, Laura, Vitale, Ilio, Vacchelli, Erika, Adjemian, Sandy, Agostinis, Patrizia, Apetoh, Lionel, Aranda, Fernando, Barnaba, Vincenzo, Bloy, Norma, Bracci, Laura, Breckpot, Karine, Brough, David, Buqué, Aitziber, Castro, Maria G, Cirone, Mara, Colombo, Maria I, Cremer, Isabelle, Demaria, Sandra, Dini, Luciana, Eliopoulos, Aristides G, Faggioni, Alberto, Formenti, Silvia C, Fučíková, Jitka, Gabriele, Lucia, Gaipl, Udo S, Galon, Jérôme, Garg, Abhishek, Ghiringhelli, Françoi, Giese, Nathalia A, Guo, Zong Sheng, Hemminki, Akseli, Herrmann, Martin, Hodge, James W, Holdenrieder, Stefan, Honeychurch, Jamie, Hu, Hong Min, Huang, Xing, Illidge, Tim M, Kono, Koji, Korbelik, Mladen, Krysko, Dmitri V, Loi, Sherene, Lowenstein, Pedro R, Lugli, Enrico, Ma, Yuting, Madeo, Frank, Manfredi, Angelo A, Martins, Isabelle, Mavilio, Domenico, Menger, Laurie, Merendino, Nicolò, Michaud, Michael, Mignot, Gregoire, Mossman, Karen L, Multhoff, Gabriele, Oehler, Rudolf, Palombo, Fabio, Panaretakis, Theochari, Pol, Jonathan, Proietti, Enrico, Ricci, Jean Ehrland, Riganti, Chiara, Rovere Querini, Patrizia, Rubartelli, Anna, Sistigu, Antonella, Smyth, Mark J, Sonnemann, Juergen, Spisek, Radek, Stagg, John, Sukkurwala, Abdul Qader, Tartour, Eric, Thorburn, Andrew, Thorne, Stephen H, Vandenabeele, Peter, Velotti, Francesca, Workenhe, Samuel T, Yang, Haining, Zong, Wei Xing, Zitvogel, Laurence, Kroemer, Guido, Galluzzi, Lorenzo, Kepp, O, Senovilla, L, Vitale, I, Vacchelli, E, Adjemian, S, Agostinis, P, Apetoh, L, Aranda, F, Barnaba, V, Bloy, N, Bracci, L, Breckpot, K, Brough, D, Buque, A, Castro, Mg, Cirone, M, Colombo, Mi, Cremer, I, Demaria, S, Dini, L, Eliopoulos, Ag, Faggioni, A, Formenti, Sc, Fucikova, J, Gabriele, L, Gaipl, U, Galon, J, Garg, A, Ghiringhelli, F, Giese, Na, Guo, Z, Hemminki, A, Herrmann, M, Hodge, Jw, Holdenrieder, S, Honeychurch, J, Hu, Hm, Huang, X, Illidge, Tm, Kono, K, Korbelik, M, Krysko, Dv, Loi, S, Lowenstein, Pr, Lugli, E, Ma, Yt, Madeo, F, Manfredi, ANGELO ANDREA M. A., Martins, I, Mavilio, D, Menger, L, Merendino, N, Michaud, M, Mignot, G, Mossman, Kl, Multhoff, G, Oehler, R, Palombo, F, Panaretakis, T, Pol, J, Proietti, E, Ricci, Je, Riganti, C, ROVERE QUERINI, Patrizia, Rubartelli, A, Sistigu, A, Smyth, Mj, Sonnemann, J, Spisek, R, Stagg, J, Sukkurwala, Aq, Tartour, E, Thorburn, A, Thorne, Sh, Vandenabeele, P, Velotti, F, Workenhe, St, Yang, Hn, Zong, Wx, Zitvogel, L, Kroemer, G, Galluzzi, L.

المصدر: OncoImmunology. 3:e955691

مصطلحات موضوعية: HSV-1, herpes simplex virus type I, Δψm, mitochondrial transmembrane potential, medicine.medical_treatment, DAMP, damage-associated molecular pattern, detection, FLT3LG, fms-related tyrosine kinase 3 ligand, Review, member 3, calreticulin, Eukaryotic translation initiation factor 2A, RFP, red fluorescent protein, 0302 clinical medicine, MOMP, mitochondrial outer membrane permeabilization, Immunology and Allergy, GFP, green fluorescent protein, HMGB1, 0303 health sciences, education.field_of_study, Toll-like receptor, BAK1, BCL2-antagonist/killer 1, H2B, histone 2B, endoplasmic reticulum stre, 3. Good health, BAX, BCL2-associated X protein, XBP1, X-box binding protein 1, cell death, Oncology, PDIA3, protein disulfide isomerase family A, 030220 oncology & carcinogenesis, endoplasmic reticulum stress, Immunogenic cell death, HSP, heat shock protein, immunotherapy, TLR, Toll-like receptor, autophagy, ATF6, activating transcription factor 6, Immunology, ICD, immunogenic cell death, EIF2A, eukaryotic translation initiation factor 2A, Guidelines, Biology, BCL2, B-cell CLL/lymphoma 2 protein, ER, endoplasmic reticulum, PI, propidium iodide, ATP release, 03 medical and health sciences, Immune system, immunogenic, medicine, IFN, interferon, Antigen-presenting cell, education, 030304 developmental biology, CALR, calreticulin, Damage-associated molecular pattern, Immunotherapy, CTL, cytotoxic T lymphocyte, HMGB1, high mobility group box 1, IL, interleukin, G3BP1, GTPase activating protein (SH3 domain) binding protein 1, APC, antigen-presenting cell, Cancer cell, DiOC6(3), 3,3′-dihexyloxacarbocyanine iodide, DAPI, 4′,6-diamidino-2-phenylindole

وصف الملف: Electronic-eCollection; application/pdf; ELETTRONICO

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e222b12ef30f7729b206437df90134bc
https://doi.org/10.4161/21624011.2014.955691